Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

732
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
732

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tumor irradiation promotes antigen dressing of dendritic cells to enhance CAR T cell persistence and efficacy in lung metastases.

Nature cancer·2026
Same author

One-step generation of T-cell receptor knock-in mice in the TCRβ locus.

The EMBO journal·2026
Same author

Submicrometre sampling of living cells by macrophages.

Nature·2026
Same author

Local gene editing of fibroblasts in tumors reveals a new cancer-associated fibroblast state.

The Journal of experimental medicine·2026
Same author

In vivo site-specific engineering to reprogram T cells.

Nature·2026
Same author

Virus-like particles enable targeted gene engineering and pooled CRISPR screening in primary human myeloid cells.

bioRxiv : the preprint server for biology·2025
Same journal

Layered social competition coordinates reproductive hierarchy formation in ants.

bioRxiv : the preprint server for biology·2026
Same journal

Combination epigenetic-targeted therapy increases the immunogenicity of poorly immunogenic sarcomas.

bioRxiv : the preprint server for biology·2026
Same journal

Loss of LanC-like proteins delays post-injury regeneration of aging skeletal muscles.

bioRxiv : the preprint server for biology·2026
Same journal

Integrative Transfer Network: Deep Transfer Learning Across Populations and Prediction Targets.

bioRxiv : the preprint server for biology·2026
Same journal

Confidence-supported label-free metabolic imaging with FPhaS phase autofluorescence microscopy.

bioRxiv : the preprint server for biology·2026
Same journal

Sequence-encoded autoinhibition couples mRNA decapping activity to phase separation.

bioRxiv : the preprint server for biology·2026
See all related articles

Related Experiment Video

Updated: Jul 2, 2025

Selecting and Isolating Colonies of Human Induced Pluripotent Stem Cells Reprogrammed from Adult Fibroblasts
13:23

Selecting and Isolating Colonies of Human Induced Pluripotent Stem Cells Reprogrammed from Adult Fibroblasts

Published on: February 20, 2012

20.0K

Ultra-high efficiency T cell reprogramming at multiple loci with SEED-Selection.

Christopher R Chang1,2,3,4, Vivasvan S Vykunta1,2,3,4, Daniel B Goodman1,2,5

  • 1Gladstone-UCSF Institute of Genomic Immunology, San Francisco, CA, USA.

Biorxiv : the Preprint Server for Biology
|February 19, 2024
PubMed
Summary
This summary is machine-generated.

A novel one-step method, Synthetic Exon/Expression Disruptors (SEEDs), efficiently enriches gene-edited T cells. This process improves purity for complex cellular therapies by removing unwanted cells.

More Related Videos

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes
10:03

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Published on: November 11, 2016

9.8K
Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

6.9K

Related Experiment Videos

Last Updated: Jul 2, 2025

Selecting and Isolating Colonies of Human Induced Pluripotent Stem Cells Reprogrammed from Adult Fibroblasts
13:23

Selecting and Isolating Colonies of Human Induced Pluripotent Stem Cells Reprogrammed from Adult Fibroblasts

Published on: February 20, 2012

20.0K
Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes
10:03

Generation of Induced Pluripotent Stem Cells from Human Melanoma Tumor-infiltrating Lymphocytes

Published on: November 11, 2016

9.8K
Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

6.9K

Area of Science:

  • Cellular immunotherapy
  • Gene editing technologies
  • Biomanufacturing processes

Background:

  • Current T cell therapies often result in heterogeneous cell mixtures due to incomplete engineering.
  • Manufacturing challenges limit the clinical application of complex, multiplex gene-edited T cell therapies.

Approach:

  • Developed Synthetic Exon/Expression Disruptors (SEEDs) for one-step enrichment of gene-edited cells.
  • SEEDs link transgene integration to endogenous surface protein disruption for immunomagnetic depletion (SEED-Selection).
  • Designed SEEDs to modify T cell specificity, co-receptor, and MHC expression loci.

Key Points:

  • Achieved up to 98% purity for single locus modifications and 90% purity for six simultaneous edits (3 knock-ins, 3 knockouts).
  • SEED-Selection effectively removes non-modified and partially edited cells.
  • The method is compatible with existing clinical manufacturing workflows.

Conclusions:

  • SEEDs offer a simple and adaptable approach for producing highly pure, complex gene-edited T cells.
  • This technology facilitates the development of next-generation cellular therapies.
  • Facilitates the production of complex gene-edited cell therapies.